Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Martin F Fromm

Director and Chair

Friedrich-Alexander Universität Erlangen-Nürnberg

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany

Articles (20)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (11)

Darja Andreev

Head of an Independent Junior Research Group focusing on Regenerative Biology

Technische Universität Dresden

GERMANY

View details

Joerg Koenig

Professor

Friedrich-Alexander Universität Erlangen-Nürnberg

GERMANY

View details

Antigoni Triantafyllopoulou

Prof. Dr.

Charité - Universitätsmedizin Berlin

GERMANY

View details

Regina Verena Taudte

Assistant Professor

Philipps-Universität Marburg

GERMANY

View details

Ashley Sanders

Professor (W3)

Charité - Universitätsmedizin Berlin

GERMANY

View details

Lucas Kreiß Roohian

Researcher

University of Cologne

GERMANY

View details

Olaf Prante

friedrich-alexander-universität erlangen-nürnberg (fau)

GERMANY

View details

Renke Maas

fau new – research center new bioactive compounds friedrich‐alexander‐universität erlangen‐nürnberg erlangen germany

GERMANY

View details

Thorsten Stiewe

Director

Philipps-Universität Marburg

GERMANY

View details

Frank Dörje

Head of Dept. , Chief Pharmacist

University Hospital Erlangen

GERMANY

View details

Markus Heinrich

Professor

Friedrich-Alexander Universität Erlangen-Nürnberg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin F Fromm

Research Interests

Make your next move.

Explore related searches

Articles (20)

A quantitative, broad-panel LC-MS/MS method for the analysis of intact steroid conjugates: A novel approach to steroid profiling for biomarker research in corticoid-dependent diseases

In vitro transporter substrate properties of previously reported biomarkers for renal OAT1/OAT3-mediated drug-drug interactions

Putative new biomarkers for renal transporter-mediated drug-drug interactions: characterization as substrates of OCT2, MATE1, and other important drug transporters

Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteins

Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs

Implications for medication safety and adherence in dermato‐oncology: The AMBORA care program for oral antitumor therapeutics

An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors

Artificial intelligence-powered chatbots in search engines: a cross-sectional study on the quality and risks of drug information for patients

Clinical–pharmaceutical assessment of medication CDSS alerts: content appropriateness and patient relevance in clinical practice

Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World Data

Metabolomic and immunophenotypic signatures in cerebral amyloid angiopathy: a pilot study

Onconephrology: The Significance of Renal Function for the Development, Diagnosis, and Treatment of Cancer Pseudo-Worsening of Kidney Function

Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in “Summaries of Product Characteristics”

New Biomarkers for Renal Transporter‐Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans

ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo

Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation

A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center

From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy

Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis

A supervised machine-learning approach for the efficient development of a multi method (LC-MS) for a large number of drugs and subsets thereof: focus on oral antitumor agents

Collaborators (11)

Darja Andreev

Joerg Koenig

Antigoni Triantafyllopoulou

Regina Verena Taudte

Ashley Sanders

Lucas Kreiß Roohian

Olaf Prante

Renke Maas

Thorsten Stiewe

Frank Dörje

Markus Heinrich

Make your next move.